These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 76680)

  • 1. Characterization of an apparently nononcogenic Marek's disease virus.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 May; 60(5):1075-82. PubMed ID: 76680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus.
    Schat KA; Calnek BW
    Infect Immun; 1978 Oct; 22(1):225-32. PubMed ID: 215543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
    J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease virus (MDV) antigens in the feather follicle epithelium: difference between oncogenic and nononcogenic MDV.
    Rangga-Tabbu C; Cho BR
    Avian Dis; 1982; 26(4):907-17. PubMed ID: 6297453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development.
    Sharma JM
    Avian Dis; 1987; 31(3):570-6. PubMed ID: 2823773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM
    Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens.
    Lee SI; Ohashi K; Morimura T; Sugimoto C; Onuma M
    Arch Virol; 1999; 144(1):45-54. PubMed ID: 10076508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of very virulent Marek's disease viruses from vaccinated chickens in Australia.
    McKimm-Breschkin JL; Faragher JT; Withell J; Forsyth WM
    Aust Vet J; 1990 Jun; 67(6):205-9. PubMed ID: 2171476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of postvaccinal immunity in Marek's disease].
    Iakovleva LS; Mazurenko NP
    Vopr Virusol; 1977; (3):331-6. PubMed ID: 198968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
    Nazerian K; Lee LF; Yanagida N; Ogawa R
    J Virol; 1992 Mar; 66(3):1409-13. PubMed ID: 1310755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the vaccinating properties of 2 variants of Marek's disease virus].
    Iakovleva LS; Merekalova ZI; Pavlovskaia AI; Plakhov IV; Mazurenko NP
    Vopr Virusol; 1977; (4):493-6. PubMed ID: 200016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pathogenicity and protective efficacy of serotype 2 Marek's disease virus from birds belonging to genus Gallus in Japan.
    Lin JA; Kodama H; Itakura C; Onuma M; Mikami T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):329-37. PubMed ID: 2161478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.